WuXi AppTec is still signing on new clients despite Biosecure threatnews2024-10-28T18:26:16+00:00October 28th, 2024|Endpoints News|
BeiGene executive reportedly under investigation in Chinanews2024-10-28T16:07:50+00:00October 28th, 2024|Endpoints News|
Growing Cannabis and Opium Poppies May Be Key to U.S. Supply Chainsnews2024-10-07T16:29:21+00:00October 7th, 2024|The New York Times|
Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countriesnews2024-10-02T23:12:20+00:00October 2nd, 2024|The New York Times|
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugsnews2024-04-15T19:47:14+00:00April 15th, 2024|The New York Times|
Israel-Hamas Truce Appears to Enter Another Day, and Morenews2023-11-28T11:02:10+00:00November 28th, 2023|The New York Times|
Covid en China: el abrupto aumento de casos impulsa una escasez de medicinasnews2022-12-26T08:00:14+00:00December 26th, 2022|The New York Times|
China’s Abrupt Covid Pivot Leaves Many Without Medicinesnews2022-12-20T10:30:40+00:00December 20th, 2022|The New York Times|
As Covid Spreads Fast in China, Beijing Isn’t in Lockdown. But It Feels Like It.news2022-12-13T12:27:12+00:00December 13th, 2022|The New York Times|
¿Por qué China no ha aprobado o desarrollado una vacuna de ARNm?news2022-02-18T21:19:19+00:00February 18th, 2022|The New York Times|
